NCT05422690
The Purpose of This Research Study is to See if Combining Gemcitabine, Cisplatin and Durvalumab Chemotherapy Treatments With a Direct Tumor Therapy Yittrium-90 (Y-90) Will Work Better Together to Shrink Tumors and Control Cancer
Phase: Phase 2
Role: Lead Sponsor
Start: Jun 12, 2024
Completion: Sep 30, 2028